高级检索

    术前血清学联合影像学检查对孤立性小肝癌微血管侵犯的预测价值

    Predictive value of preoperative serological indicators combined with imaging examination for microvascular invasion in solitary small hepatocellular carcinoma

    • 摘要: 目的 基于术前血清学指标及影像学检查分析孤立性小肝癌微血管侵犯的危险因素,并构建列线图预测模型。方法 选取2020年6月—2023年12月于徐州医科大学附属医院肝胆胰外科行根治性肝切除术的孤立性小肝癌患者205例,收集临床资料进行回顾性分析。将患者按7∶3的比例随机分为训练组(143例)与验证组(62例)。通过LASSO回归与logistic回归分析确定发生微血管侵犯的危险因素,构建列线图模型。采用受试者操作特征(ROC)曲线、校准曲线和临床决策曲线评估预测模型的有效性,并在验证组进行模型效能验证。结果 LASSO回归与logistic回归分析显示,肿瘤最大直径>2.65 cm、异常凝血酶原(PIVKA-Ⅱ)>40 AU/L、中性粒细胞与淋巴细胞比值(NLR)>1.92、纤维蛋白原与血清白蛋白比值(FAR)>0.056、包膜不完整是孤立性小肝癌患者发生微血管侵犯的独立危险因素。基于上述指标构建列线图预测模型。训练组和验证组预测孤立性小肝癌发生微血管侵犯的ROC曲线结果显示,训练组和验证组联合模型的预测价值均高于单一变量模型,训练组的曲线下面积(AUC)为0.866(95%CI 0.799~0.932),验证组的AUC为0.854(95%CI 0.748~0.960)。Hosmer-Lemeshow检验结果显示,训练集χ2=4.57,P=0.802,验证集χ2=11.4,P=0.122,提示训练组与验证组预测概率与术后病理结果之间拟合度较高,预测模型具有较好的一致性。决策曲线分析显示,训练集阈值概率为0.05~0.75,验证组阈值概率为0.05~0.65,提示该模型具有较高的预测能力,可有效预测微血管侵犯的发生。结论 基于肿瘤最大直径>2.65 cm、PIVKA-II>40 AU/L、NLR>1.92、FAR>0.056和包膜不完整所构建的列线图预测模型对术前预测孤立性小肝癌患者发生微血管侵犯具有较高的价值,可指导临床决策。

       

      Abstract: Objective To explore the risk factors of microvascular invasion (MVI) in solitary small hepatocellular carcinoma based on preoperative serological indicators and imaging examination, and to construct a nomogram prediction model. Methods A total of 205 patients with solitary small hepatocellular carcinoma who underwent radical hepatectomy at Department of Hepatobiliary Pancreatic Surgery, the Affiliated Hospital of Xuzhou Medical University, from June 2020 to December 2023 were enrolled, and their clinical data were retrospectively analyzed. The patients were randomly divided into a training group (n=143) and a validation group (n=62) in a 7∶3 ratio. LASSO regression and logistic regression analysis were used to identify risk factors for MVI, and a nomogram prediction model was constructed. Receiver operating characteristic (ROC) curves, calibration curve, and clinical decision curve were plotted to evaluate the model's efficiency, and model performance was verified in the validation group. Results LASSO and logistic regression analyses revealed that tumor maximum diameter>2.65 cm, protein induced by vitamin K absence or antagonist-Ⅱ (PIVKA-Ⅱ)>40 AU/L, neutrophil-to-lymphocyte ratio (NLR)>1.92, fibrinogen-to-albumin ratio (FAR)>0.056, and incomplete capsule were independent risk factors for MVI in patients with solitary small hepatocellular carcinoma. A nomogram prediction model was constructed based on these indicators. ROC curves for predicting MVI in the training and validation groups showed that the combined model in both groups had a higher predictive value than single-variable models, with areas under the curve (AUC) of 0.866 (95%CI 0.799-0.932) for the training group and 0.854 (95%CI 0.748-0.960) for the validation group. The Hosmer-Lemeshow test showed a high degree of fit between predicted probabilities and postoperative pathology results, with χ2=4.57, P=0.802 in the training set, and χ2=11.4, P=0.122 in the validation set, indicating good consistency of the predictive model. Decision curve analysis showed threshold probabilities of 0.05-0.75 for the training group and 0.05-0.65 for the validation group, suggesting that the model has high predictive ability and can effectively predict MVI occurrence. Conclusions The nomogram prediction model constructed based on tumor maximum diameter>2.65 cm, PIVKA-II>40 AU/L, NLR>1.92, FAR>0.056, and incomplete capsule has high value for preoperative prediction of MVI in patients with solitary small hepatocellular carcinoma, providing guidance for clinical decision-making.

       

    /

    返回文章
    返回